Novo Nordisk Expands Wegovy Production with Ireland Facility Investment

Danish drugmaker Novo Nordisk is investing in a new facility in Ireland to expand its production capacity for the newly launched weight-loss pill Wegovy, aiming to compete with Eli Lilly.

2 Mar, 15:57 — 2 Mar, 15:57

Post Share

Sources

Showing 1 of 1 sources

cnbcMostly Factual37d ago

Why Novo Nordisk's Ireland expansion is key to fighting off Eli Lilly

Novo Nordisk is investing in a facility in Ireland as it expands its production capacities of the newly launched Wegovy pill, the Danish drugmaker said Monday.

Read full article →

PERSPECTA

PERSPECTA

Novo Nordisk Expands Wegovy Production with Ireland Facility Investment

Sources

Why Novo Nordisk's Ireland expansion is key to fighting off Eli Lilly

Related Stories

Manila Water prepares for summer heat and high demand

Ozempic Patent Expiration Leads to Flood of Generics and Abuse Concerns in Asia

Measles Outbreak Spreads from Rural to Urban Utah

Philippines Announces Results of April 2026 Physicians Licensure Examination

PERSPECTA